Wedge Networks Inc. (Wedge), a global leader in software defined Orchestrated Real-time Threat Prevention, is pleased to announce its 2021 Audited Consolidated Financial Statements have been released and are now available to shareholders.
الإعلام
Wedge Networks Inc. (Wedge), a global leader in software defined Orchestrated Real-time Threat Prevention, is pleased to announce its 2021 Audited Consolidated Financial Statements have been released and are now available to shareholders.
Biotricity Inc. (Biotricity) today announced a significant milestone of recording and analyzing over 2 billion heartbeats for Atrial Fibrillation (AFib), the most common type of cardiac arrhythmia and a leading cause of stroke. Bioflux®, Biotricity’s high-precision, single-unit mobile cardiac telemetry device that provides real-time monitoring and transmission of the patient’s ECG information, has captured billions of heartbeats to date, monitored in real-time by Bioflux’s built in algorithms, certified cardiac technicians and benchmarked by Artificial Intelligence (AI).
Biotricity Inc. (Biotricity), today announced that it will be carrying out an NIH-sponsored Phase I study of Bioflux-AI, Biotricity’s innovative artificial intelligence-driven (‘AI’) system of real-time monitoring and prediction technology, in subjects with Chronic Kidney Disease (‘CKD’). The risk of ischemic and hemorrhagic stroke is 5 to 30 times higher in patients with CKD and has a mortality rate of up to three times that of the general population. Effective stroke risk prediction is currently flawed in CKD patients because comorbidities often remain undiagnosed and stroke risk stratification schemes do not consider stages of CKD. Additionally, the detection of stroke-risk variations due to dialysis requires real-time risk monitoring, which is unavailable to date.
Biotricity Inc. (Biotricity) today announced its financial results for its fiscal 2023 first quarter ended June 30, 2022. Dr. Waqaas Al-Siddiq, Founder & CEO of Biotricity, commented, “We are pleased with our year-over-year revenue growth and ability to maintain gross margins at 60% as we begin to roll out our new Biotres and Bioheart products lines through our established network. Both new product offerings will complement the existing platform we have built through Bioflux to make the Biotricity ecosystem an all-in-one go-to solution for cardiologists. Additionally, because Biotres is a higher volume wireless wearable cardiac monitoring device as compared to Bioflux, we expect to expand our distribution to include channels such as Hospital Networks or Integrated Delivery Networks.”
Wedge Networks Inc. (Wedge) today announced its partnership with SecureServ, an Australian-based cyber security solutions and network performance distributor. The partnership will afford SecureServ the opportunity to deliver powerful new threat prevention with innovative solutions for Enterprises, Small Businesses, Government Departments, Service Providers and Data Centres, while simultaneously expanding its partner community in the region.
Biotricity Inc. (Biotricity) today announced its financial results for its fiscal 2022 fourth quarter and year ended March 31, 2022. Dr. Waqaas Al-Siddiq, Founder & CEO of Biotricity, commented, “Fiscal 2022 was a pivotal year for Biotricity as we made significant strides in our product development and commercialization strategy.
